Traditional approaches to HCP segmentation are no longer sufficient. The challenge now is to maintain personalization at scale while managing large territories and diverse customer bases.
Kunal Girotra
Advertisement
Senior Manager, Strategy & Enablement, Pfizer
Articles by Kunal Girotra
Advertisement
Latest Updated Articles
Beyond the Data: Making HCP Analytics Actually Work for Commercial TeamsFebruary 21st 2025
Advertisement
Advertisement
Trending on PharmExec
1
Everything You Need to Know About the AstraZeneca–Bristol Myers Squibb Merger Rumors
2
The Significance of FDA’s First Warning Letter for Inappropriate Use of AI
3
Jazz Pharmaceuticals to Acquire Actio Biosciences for $1.32 Billion
4
M&A Roundup: Novo Nordisk Enters AI Drug Discovery Partnership with Amazon, Innate Pharma Partners with Sobi, Innovent Enters Commercialization Agreement with Daiichi Sankyo
5